Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwifes has received generous funds from Huntleigh Healthcare for the next 3 years.

In 1980, University of Oxford Professors Geoffrey Dawes and Chris Redman initiated a pioneering programme to computerise the recognition of diagnostic features of electronic fetal heart rate traces before labour. The Dawes-Redman CTG Analysis System represents one of the University’s most successful and long-standing clinical  advances, and is widely recognised as the reference standard for the assessment of fetal health during pregnancy.

The system has undergone extensive testing and continual refinement over the last 40 years and supported by over 70 peer-reviewed articles, has a proven level of performance accepted by clinicians worldwide.

The Dawes-Redman antepartum CTG  is recommended by NHS England as the best way to assess the fetus before labour. It analyses the fetal heart and measures a number of criteria. These provide a readout of the hypoxic status of the baby since the fetal heart is controlled by the fetal brain. 

The requirement for training in the use of CTG has been highlighted by a number of clinical bodies including the Saving Babies Lives Care Bundle 2, the Healthcare Safety  Investigation Branch and the Ockendon Report. 

The team at Oxford comprising Professor Redman (co-inventor of the Dawes-Redman system), Beth Albert (Director of Dawes-Redman Education) and Manu Vatish (Professor of Obstetrics) have created a bespoke education programme for Dawes-Redman to address these needs  This has only been possible by the generous support of Huntleigh Healthcare who have pledged £131,600 over three years. 

Prof Manu Vatish commented: "The Nuffield Department of Women's & Reproductive Health, University of Oxford are extremely grateful for Huntleigh Healthcare's generous donation in support of the educational training programme for Dawes-Redman CTG Analysis."

The virtual training sessions are led by Beth Albert, who is a Lead Midwife/ Manager in the Fetal Maternal Medicine Unit at Oxford University Hospital Foundation Trust. She is a specialist midwife for Dawes-Redman CTG monitoring and the lead for education.

 

 

Similar stories

New Professor of Obstetrics Title

Enormous well done to our new Professor Sally Collins - she was conferred the title of Professor of Obstetrics by the University's Medical Sciences Division Board.

INTERCOVID Study cited in the New Yorker

Fantastic news for our team who have been working on the INTERCOVID Study, which launched in April 2020. This week on 12th August 2022, the research findings cited in the New Yorker! This work was a combined effort from 43 institutions in 18 countries and involved more than two thousand pregnant women.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Pregnancy is more likely with urine tests and timed intercourse

Dr Tatjana Gibbons leads study that suggests a woman's chance of conceiving is improved by using urine tests to detect the optimum time for intercourse, but further research is still needed to assess whether timed intercourse via any ovulation detection method creates a difference in live births and pregnancy rates.

First UK pilot study of newborn screening for spinal muscular atrophy (SMA) launched in Oxford

Spinal muscular atrophy (SMA) is a rare, but treatable, genetic disease affecting approximately 1 in 10,000 births, and it typically presents in infancy and early childhood.

Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021

Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.